ロード中...
Advances in the treatment of soft tissue sarcoma: focus on eribulin
Eribulin mesylate is a synthetic derivative of halichondrin B isolated from a marine sponge. Its mechanism of action is through microtubule inhibition, which is different from that of taxanes. Eribulin has been approved for the treatment of metastatic breast cancer and more recently for non-operable...
保存先:
| 出版年: | Cancer Manag Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5798537/ https://ncbi.nlm.nih.gov/pubmed/29440930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S143019 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|